Orexigenic ghrelin secretion in HCV-infected patients with telaprevir- or simeprevir-based triple therapy

被引：0
|
作者：
Aoyama, Toru [1 ]
Nagoshi, Sumiko [1 ]
Yamamoto, Ryuichi [1 ]
Yamaguchi, Naomi [1 ]
Ohno, Shino [1 ]
Yakabi, Koji [1 ]
机构：
[1] Saitama Med Univ, Saitama Med Ctr, Dept Gastroenterol & Hepatol, Saitama, Japan
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1019
引用
收藏
页码：696A / 696A
页数：1
相关论文
共 50 条
  • [31] Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy
    Deneke, M. G.
    Dranoff, J. A.
    Duarte-Rojo, A.
    [J]. REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2014, 79 (01): : 64 - 66
  • [32] Evaluation of Simeprevir-Based Triple Therapy Using Pegylated-Interferon-α and Ribavirin in Patients With Hepatitis C Virus Genotype-1b Infection
    Nakatani, Toshiya
    Fujinaga, Yukihisa
    Tomooka, Fumimasa
    Ishida, Koji
    Kaya, Daisuke
    Takagi, Hirotetsu
    Saikawa, Soichiro
    Nagamatsu, Shinsaku
    Shimozato, Naotaka
    Matsuo, Hideki
    Kikuchi, Eiryo
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S884 - S884
  • [33] HCV KINETICS AND QUASISPECIES EVOLUTION WITHIN THE FIRST HOURS OF TELAPREVIR-BASED TRIPLE THERAPY IN PREVIOUSLY TREATED HCV-PATIENTS
    Cento, V.
    De Luca, F.
    Valenti, F.
    Tontodonati, M.
    Di Maio, V. C.
    Bellocchi, M. C.
    Armenia, D.
    Carioti, L.
    Trave, F.
    Cacciatore, P.
    Madeddu, G.
    Bertoli, A.
    Angelico, M.
    Babudieri, S.
    Parruti, G.
    Ceccherini-Silberstein, F.
    Perno, C. F.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S6 - S6
  • [34] High Early Response Rates with Protease Inhibitor Triple Therapy in a Multicenter Cohort of HCV-Infected Patients Awaiting Liver Transplantation
    Vernal, Elizabeth C.
    Terry, Nicole
    Lukose, Thresiamma
    Mentore, Kimiknu
    Olsen, Sonja K.
    Fox, Alyson N.
    Laurin, Jacqueline
    Satoskar, Rohit
    Dove, Lorna M.
    Shetty, Kirti
    Brown, Robert S.
    [J]. HEPATOLOGY, 2012, 56 : 218A - 218A
  • [35] Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV-infected patients
    Lucejko, Mariusz
    Flisiak, Robert
    [J]. ANTIVIRAL THERAPY, 2018, 23 (02) : 149 - 156
  • [36] Telaprevir-based therapy in G1 HCV-infected patients with prior null response, partial response or relapse to peginterferon/ribavirin: REALIZE trial final results
    Mullhaupt, Beat
    Zeuzem, Stefan
    Andreone, Pietro
    Pol, Stanislas
    Lawitz, Eric
    Diago, Moises
    Roberts, S.
    Focaccia, Roberto
    Younossi, Zobair
    Foster, Graham
    Horban, Andrzej
    Pockros, Paul. J.
    Van Heeswijk, Rolf
    de Meyer, Sandra
    Luo, Donghan
    Picchio, Gaston
    Beumont, Maria
    [J]. SWISS MEDICAL WEEKLY, 2011, 141 : 6S - 6S
  • [37] Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study
    Verna, Elizabeth C.
    Saxena, Varun
    Burton, James R.
    O'Leary, Jacqueline G.
    Dodge, Jennifer L.
    Stravitz, Richard T.
    Levitsky, Josh
    Trotter, James F.
    Everson, Gregory T.
    Brown, Robert S., Jr.
    Terrault, Norah A.
    [J]. TRANSPLANTATION, 2015, 99 (08) : 1644 - 1651
  • [38] Serious Adverse Events and Hepatic Decompensation in Hepatitis C Virus infected Patients on Sofosbuvir- and/or Simeprevir-based Therapies
    Perumalswami, Ponni
    Bichoupan, Kian
    Yalamanchili, Rachana
    Harty, Alyson
    Gardenier, Donald
    Ng, Michel
    Motamed, David B.
    Khaitova, Viktoriya
    Bach, Nancy
    Chang, Charissa Y.
    Im, Gene Y.
    Leong, Jennifer
    Ku, Lawrence
    Schiano, Thomas D.
    Dieterich, Douglas
    Branch, Andrea D.
    [J]. HEPATOLOGY, 2014, 60 : 694A - 695A
  • [39] Simeprevir versus telaprevir in combination with pegylated interferon and ribavirin in HCV genotype 1-infected patients: the Phase III ATTAIN study
    Hinrichsen, H.
    Reddy, K.
    Zoulim, F.
    Weiland, O.
    Horban, A.
    Taliani, G.
    Stanciu, C.
    Villamil, F.
    George, J.
    Dammers, E.
    Fu, M.
    Kurland, D.
    Lenz, O.
    Ouwerkek-Mahadevan, S.
    Verbinnen, T.
    Schlag, M.
    Jessner, W.
    Zeuzem, S.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 6 - 7
  • [40] Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure
    Ogawa, E.
    Furusyo, N.
    Dohmen, K.
    Kajiwara, E.
    Kawano, A.
    Nomura, H.
    Takahashi, K.
    Satoh, T.
    Azuma, K.
    Nakamuta, M.
    Koyanagi, T.
    Kotoh, K.
    Shimoda, S.
    Hayashi, J.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 (12) : 992 - 1001
12345